Skip to main content

CP2D

Generic: CP2D

Verified·Apr 23, 2026
Manufacturer
Fenwal, Inc.
NDC
87069-455
Route
INTRAVENOUS
ICD-10 indication
R69

Affordability Check

How much will you actually pay for CP2D?

In 30 seconds, see every legitimate way to afford CP2D — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About CP2D

What is this medication? CP2D, which stands for Citrate Phosphate Double Dextrose, is a specialized anticoagulant and preservative solution used primarily during the collection of whole blood. Its main function is to prevent blood from clotting after it has been drawn from a donor, ensuring that the blood remains in a liquid state suitable for processing or transfusion. By inhibiting the coagulation cascade, the solution protects the physical integrity of the blood components throughout the collection process. This medication contains specific concentrations of sodium citrate, citric acid, monobasic sodium phosphate, and a high amount of dextrose. The double dextrose formulation provides an essential energy source for red blood cells, which helps maintain their viability and metabolic function during refrigerated storage. Additionally, the phosphate acts as a buffer to stabilize the pH levels of the blood, ultimately extending the useful shelf life of the collected units for medical use.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for CP2D. Official source: DailyMed (NLM) · Label effective Nov 6, 2025

Warnings and precautions
Warnings and precautions Warnings Not for direct intravenous infusion. Single-use container – discard unused portion. (do not reuse) Do not use unless the solution is clear and no leaks are detected. Precautions Use only with automated red-cell apheresis devices and follow the Operator’s Manual. Refer to the package insert for complete instructions. Storage/handling: Store at 25 °C/77 °F, avoid excessive heat, protect from freezing. Pouch is a moisture barrier; handle to maintain package integrity. Warnings and precautions

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.